Finally, as above indicated, based on the consideration that a decrease in the abundance and diversity of gut microbiota-specific genera may putatively trigger IBD-initiating events [134], the possible interactions of S100B with microbiota have been recently investigated both in silico [135] and experimentally in vivo in mice [136]. The gene discussed is S100B; the disease is inflammatory bowel disease.